Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Thulin

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|July 1, 1977
Enhancement of hydralazine bioavailability by foodA Melander, K Danielson, A Hanson, et al.
Blood Pressure|June 15, 2000
Organ damage in treated middle-aged hypertensives compared to normotensives: results from a cross-sectional study in general practiceI Enström, I M Burtscher, J Eskilsson, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 23, 1999
Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study GroupT Thulin, A Lehtonen, C Dahlöf, et al.
Acta Medica Scandinavica|January 1, 1980
Comparison of energy and nutrient intakes in women with high and low blood pressure levelsT Thulin, M Abdulla, I Dencker, et al.
Acta Medica Scandinavica|January 1, 1976
Reduction of isoniazid bioavailability in normal men by concomitant intake of foodA Melander, K Danielson, A Hanson, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1980
Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden studyB Scherstén, T Thulin, J Kuylenstierna, et al.
Cardiovascular Drugs and Therapy|December 1, 1994
Efficacy and tolerability of felodipine ER and diltiazem SR as monotherapy in primary hypertension: a double-blind randomized studyT Thulin, H Almkvist, L Berglund, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1985
Monitoring 24-hour blood pressure in a drug trial. Evaluation of a noninvasive deviceG Berglund, U De Faire, J Castenfors, et al.
British Journal of Clinical Pharmacology|December 1, 1984
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patientsB Dahlöf, M Danielson, O Andersson, et al.
Acta Medica Scandinavica|January 1, 1984
A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensivesO R Nilsson, J H Atterhög, J Castenfors, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|July 1, 1977
Enhancement of hydralazine bioavailability by foodA Melander, K Danielson, A Hanson, et al.
Blood Pressure|June 15, 2000
Organ damage in treated middle-aged hypertensives compared to normotensives: results from a cross-sectional study in general practiceI Enström, I M Burtscher, J Eskilsson, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 23, 1999
Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study GroupT Thulin, A Lehtonen, C Dahlöf, et al.
Acta Medica Scandinavica|January 1, 1980
Comparison of energy and nutrient intakes in women with high and low blood pressure levelsT Thulin, M Abdulla, I Dencker, et al.
Acta Medica Scandinavica|January 1, 1976
Reduction of isoniazid bioavailability in normal men by concomitant intake of foodA Melander, K Danielson, A Hanson, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1980
Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden studyB Scherstén, T Thulin, J Kuylenstierna, et al.
Cardiovascular Drugs and Therapy|December 1, 1994
Efficacy and tolerability of felodipine ER and diltiazem SR as monotherapy in primary hypertension: a double-blind randomized studyT Thulin, H Almkvist, L Berglund, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1985
Monitoring 24-hour blood pressure in a drug trial. Evaluation of a noninvasive deviceG Berglund, U De Faire, J Castenfors, et al.
British Journal of Clinical Pharmacology|December 1, 1984
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patientsB Dahlöf, M Danielson, O Andersson, et al.
Acta Medica Scandinavica|January 1, 1984
A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensivesO R Nilsson, J H Atterhög, J Castenfors, et al.
Pageof 6